HIT Consultant

MAY 18, 2023

What You Should Know: ArisGlobal , a provider of life sciences software acquires SPORIFY , the trusted substances, products, organizations and referentials (SPOR) data harmonization technology solution for five of the world’s top 20 largest pharmaceutical companies. Financial details of the acquisition were not disclosed.

Life Sciences 52

Life Sciences Pharmaceuticals Patient Safety Regulations 52

HIT Consultant

APRIL 6, 2022

. – Doceree’s platform offers real-time measurement solutions to understand the online journey of healthcare professionals (HCPs) to enrich communications that will improve the health outcomes of patients. The capital raised comes when digital ad spending for the healthcare and pharma industry increased by 18% in 2021 up to $11.25

Life Sciences 98

Life Sciences Pharmaceuticals Regulations Healthcare 98

HIT Consultant

AUGUST 21, 2022

We are entering a new era of patient treatment options thanks to cutting-edge technologies that are changing the way life science companies approach and execute pharmaceutical research. 21 st Century Patient Treatment for Rare Illnesses. Making Clinical Trials Data More Accessible for HCPs & Patients.

Life Sciences 97

Life Sciences Pharmaceuticals Patient Safety Regulations 97

HIT Consultant

NOVEMBER 6, 2023

Beginning with consumer healthcare devices that individuals use in their own homes will make the Cyber Trust Mark a competitive differentiator among device manufacturers, one that should quickly usher in better cybersecurity features. vulnerabilities. This has to change: the consequences are too severe not to, and it will force HDOs’ hands.

Healthcare 111

Healthcare Life Sciences Pharmaceuticals Regulations 111

HIT Consultant

FEBRUARY 1, 2024

Mike Szczesny, Owner & VP of EDCO Awards & Specialties Influencer marketing in the pharmaceutical industry is a complex issue with reasonable arguments on multiple sides. Influencers can establish trust, connect with diverse audiences, and shape perceptions around healthcare solutions.

Pharmaceuticals 111

Pharmaceuticals Regulations Doctors Prevention 111

Healthcare ECONOMIST

MAY 22, 2024

Many large and small pharmaceutical firms rely on contract manufacturers in China to actually make the drugs they have invented. Would current contracts that pharmaceutical firms have with these “companies of concern” be impacted? ” Bottom line, how much will this legislation cost life science companies?

Pharmaceuticals 56

Pharmaceuticals Life Sciences Regulations 56

Health Populi

JUNE 24, 2021

The economic and healthcare system impacts of this were explored in the Post-Covid Healthcare Landscape , delivered by Fitch Solutions’ Jamie Davies and Beau Noafshar, leaders in the Pharmaceuticals, Healthcare, and Medical Devices groups. PPP in the US), and in emerging markets, currency weakness. spends on NASA.

Healthcare 108

Healthcare Pharmaceuticals Population Health Regulations 108

Healthcare ECONOMIST

DECEMBER 28, 2022

 In the context of this fast-moving political debate, FTI Consulting supported INTERPAT, a non-profit biopharmaceutical consortium, and the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) in developing a White Paper and peer-reviewed article on the role of IP in the biopharmaceutical sector.

Life Sciences 71

Life Sciences Pharmaceuticals Medical Technology Regulations 71

HIT Consultant

DECEMBER 19, 2023

Gary Shorter – Head, AI and Data Science, IQVIA Technologies In the healthcare ecosystem, automation and data intelligence continue to gain momentum as artificial intelligence (AI) and machine learning (ML) are integrated to streamline and accelerate processes.

Pharmaceuticals 105

Pharmaceuticals Quality Control Process improvement Integration 105

HIT Consultant

APRIL 23, 2024

What You Should Know: – Deciphex , a leading digital pathology company based in Dublin, Ireland, has announced a collaborative effort with Novartis , a prominent multinational pharmaceutical corporation.

Pharmaceuticals 64

Pharmaceuticals Regulations Life Sciences Healthcare 64

HIT Consultant

JULY 25, 2022

Lauren Ohlsson, Lead of Industry Solutions, Pharmaceutical and Healthcare, at VDX.tv. Consumers continue to cut ties with traditional TV and cable services, prompting industries like the prescription pharmaceutical industry to evolve their marketing mix to accommodate emerging media. . About Lauren Ohlsson.

Pharmaceuticals 98

Pharmaceuticals Accountability Regulations Integration 98

HIT Consultant

JANUARY 24, 2022

As artificial intelligence (AI) and machine learning drive innovation and disruption in clinical trials and precision medicine, questions around the responsible use of AI have moved to the forefront of debates among healthcare stakeholders – patients, providers, regulatory authorities, payors and sponsors. It’s why the U.S.

Life Sciences 98

Life Sciences Pharmaceuticals Regulations Doctors 98

Health Populi

APRIL 24, 2019

The 2019 Edelman Trust Barometer measured the biggest gap in trust for the healthcare industry between the U.S. Fewer American women, too, trust the healthcare industry than men do. In this study, the healthcare industry is comprised of five segments: hospitals and clinics; pharma; biotech (separate from pharma); consumer health (e.g.,

Healthcare 83

Healthcare Life Sciences Hospitals Pharmaceuticals 83

HIT Consultant

OCTOBER 16, 2023

Therefore, consultation with a healthcare provider is critical for anyone considering Ozempic for weight loss. While pharmaceutical companies are bound by rigorous standards and regulations, independent influencers are not held to the same criteria.

Doctors 98

Doctors Pharmaceuticals Regulations Healthcare Providers 98

Health Advances

SEPTEMBER 15, 2020

Despite the well-publicized ongoing political issues in Hong Kong SAR, Health Advances believes that HKEX’s unique position and the sustained growth of China’s healthcare industry will continue to attract Chinese biotech companies with domestic and global-focused strategies to the exchange. HKEX: Opening a Biotech Chapter.

Pharmaceuticals 98

Pharmaceuticals Biotechnology Life Sciences Healthcare 98

Health Advances

JULY 14, 2022

But we expect to see a change, with some traditional 361 CTPs taking the leap (willingly or unwillingly) into Biologics License Application (BLA) territory as well as innovators turning to development of products that can be considered pharmaceuticals.

Pharmaceuticals 52

Pharmaceuticals Regulations Healthcare Life Sciences 52

HIT Consultant

DECEMBER 14, 2022

Cuban felt like a great guy to approach with an idea for a healthcare startup. Healthcare is hard,” he sighed. Healthcare is hard. It’s a complex world filled with regulations and many layers of stakeholders. Healthcare transformation is trending in the right direction. Healthcare is hard. Cuban isn’t wrong.

Patient Experience 98

Patient Experience Nursing Pharmaceuticals Healthcare 98

HIT Consultant

MAY 31, 2023

Harshit Jain MD, Founder and Global CEO of Doceree Consolidation and the threat of monopolization in healthcare are rising. The pharmaceutical industry has experienced a wave of accelerated consolidation since 2010. And it’s not just in healthcare. Monopolization leads to absolute power and fixed pricing.

Pharmaceuticals 96

Pharmaceuticals Healthcare Healthcare Innovation Telemedicine 96

HIT Consultant

JUNE 7, 2023

Kayt Leonard, Global Health Care and Life Sciences Strategic Advisor at SAS We hear it every day, right? Articles and headlines touting “the healthcare industry is constantly evolving and changing” to be more consumer-focused and patient-centric. But is that really all that true? questionable. questionable. And it’s 2023!

Life Sciences 52

Life Sciences Healthcare Doctors Pharmaceuticals 52

Health Populi

OCTOBER 8, 2019

Pricing failure, the second big waste factor, is predominantly challenged by pharmaceutical/prescription drug pricing based on this research. More savings would accrue through the quicker adoption of value-based payment models, the authors assert, where clinicians take on financial risk for managing population health. patients). health care.

Pharmaceuticals 108

Pharmaceuticals Life Sciences Medicare Accountability 108

HIT Consultant

JANUARY 13, 2022

Jon-Michael Smith, Head of Healthcare & Life Science Analytics – Data Integration at Qlik. At the time, the 2009 HITECH Act and the introduction of the Meaningful Use program represented a momentous step in healthcare’s digital transformation.

Healthcare Analytics 52

Healthcare Analytics Health Data Life Sciences Healthcare 52

Health Populi

DECEMBER 11, 2019

In this 14th year of the publication, PwC polled executives from payers, providers, and pharma/life science organizations. Clearly, digital transformation is top-of-mind for healthcare organizations pondering their workforce strategies for 2020. Their poll of consumers found that 7 in 10 U.S.

Healthcare 77

Healthcare Life Sciences Regulations Health Data 77

Sheppard Health Law

AUGUST 20, 2021

California Life Sciences Ass’n v. Ca); Regeneron Pharmaceuticals v. 2] California Life Sciences Ass’n v. FOOTNOTES. [1] 1] Association of Community Cancer Centers v. 8:20–cv–03531 (D. 3:20–cv–08603 (N.D. 7:20–cv–10488 (S.D.N.Y.); and Community Oncology Alliance, Inc. 3:20–cv–08603 (N.D.

Life Sciences 52

Life Sciences Medicare Pharmaceuticals Quality of Care 52

HIT Consultant

APRIL 7, 2023

Additionally, digital transformation can support medical research and drive innovation in healthcare, as well as generate new revenue streams. Data Interoperability: Hospitals need to be able to share data with other healthcare providers and organizations in order to coordinate care and avoid duplicate tests and treatments.

Hospitals 52

Hospitals Life Sciences Accountability Integration 52

Health Populi

MAY 14, 2018

Smart Pharmaceuticals Index (NQSSPH) from May 11, 2018, the date when POTUS and Secretary Azar made their announcement. Healthcare will be among the top 2018 mid-term election issues, and prescription drug costs rank top-of-mind to healthcare voters. The graph is the Nasdaq U.S.

Pharmaceuticals 48

Pharmaceuticals Medicare Medicaid Prevention 48

Health Populi

MARCH 6, 2019

That would be profits made by pharmaceutical companies, cited by 80% of respondents. David Lazarus of the LA Times noted that the Lilly move illustrates just “how broken our healthcare system really is.” The biggest culprit/contributor to prescription drug prices? consumers were asked.

Pharmaceuticals 59

Pharmaceuticals Regulations Doctors Medicare 59

Health Populi

FEBRUARY 4, 2020

voters in 2020 quite like supporting Medicare’s ability to negotiate drug prices with pharmaceutical companies, shown by the October 2019 Kaiser Family Foundation Health Tracking Poll. Few issues unite U.S. We’re at a moment when the U.S.

Pharmaceuticals 83

Pharmaceuticals Regulations Medicare Life Sciences 83